antibiotic

no-antibiotic

P

logistics

n

360

214

Age, median [Q1, Q3]

55.00 [43.00, 65.00]

54.00 [43.00, 64.00]

0.279

/

Male, n

220

132

0.930

/

Male, (%)

61.11%

61.68%

ethnicity

white, n

210

135

white, (%)

58.33%

63.08%

BLACK/AFRICAN AMERICAN, n

39

30

BLACK/AFRICAN AMERICAN, (%)

10.83%

14.02%

AMERICAN INDIAN/ALASKA NATIVE, n

1

1

AMERICAN INDIAN/ALASKA NATIVE, (%)

0.28%

0.47%

PORTUGUESE, n

4

1

PORTUGUESE, (%)

1.11%

0.47%

UNKNOWN, n

57

13

UNKNOWN, (%)

15.83%

6.07%

ASIAN, n

7

13

ASIAN, (%)

1.94%

6.07%

OTHER, n

14

9

OTHER, (%)

3.89%

4.21%

HISPANIC/LATINO, n

16

9

HISPANIC/LATINO, (%)

4.44%

4.21%

UNABLE TO OBTAIN, n

12

3

UNABLE TO OBTAIN, (%)

3.33%

1.40%

Aps III, median [Q1, Q3]

63.00 [44.75, 87.25]

50.50 [37.25, 76.75]

<0.001*

0.170

inSOFA, median [Q1, Q3]

1.00 [0, 4.00]

1.00 [0, 3.00]

0.010

0.174

▲SOFA, median [Q1, Q3]

1.00 [−1.00, 3.00]

0 [−1.00, 2.00]

0.062

/

Glu_meana (mmol/L), median

[Q1, Q3]

7.76 [6.60, 9.43]

7.82 [6.42, 9.15]

0.951

/

Glu_cvb, median [Q1, Q3]

0.24 [0.17, 0.35]

0.23 [0.16, 0.31]

0.287

/

Glu_frequency* (n/day), median [Q1, Q3]

4.66 [3.58, 6.22]

4.50 [3.39, 6.81]

0.969

/

LOS in ICUc, median [Q1, Q3]

5.81 [3.16, 13.26]

3.93 [2.79, 7.62]

<0.001*

/

LOS in hospitald, median [Q1, Q3]

16.86 [9.60, 27.12]

13.06 [7.70, 22.70]

0.002

/

antibiotic day, median [Q1, Q3]

3.00 [1.00, 5.00]

0 [0, 0]

-

/

die, n

186

79

<0.001*

0.033

die, (%)

51.67%

36.92%

blood-infection, n

110

47

0.026

/

blood-infection, (%)

30.56%

21.96%

Abdominal-infection, n

50

25

0.522

/

Abdominal-infection, (%)

13.89%

11.68%

urinary-infection, n

46

18

0.131

/

urinary-infection, (%)

12.78%

8.41%

respiratory-infection, n

61

24

0.069

/

respiratory-infection, (%)

16.94%

11.21%

diabetes, n

114

85

0.057

0.040

diabetes, (%)

31.67%

39.72%

hypoglycemia, n

4

7

0.111

/

hypoglycemia, (%)

1.82%

5.30%

die, n

63

17

0.001

0.090

die, (%)

17.50%

7.94%

hyperlipidemia, n

79

36

0.161

0.122

hyperlipidemia, (%)

35.91%

27.27%